Literature DB >> 25152339

Impact of hyperhidrosis on quality of life and its assessment.

Henning Hamm1.   

Abstract

Hyperhidrosis is an embarrassing condition that may interfere with routine activities, cause emotional distress, and disturb both professional and social lives of patients. Objective examination is variable and unreliable, so efforts have been made in the last 15 years to substantiate the limitations of these patients, especially in primary focal hyperhidrosis. Almost all therapeutic studies use standardized or self-designed instruments to evaluate the impact of the disease on quality of life and the improvement achieved by treatment. This article gives an overview of the difficulties with which patients with hyperhidrosis are confronted and of research investigating the restrictions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; Dermatology Life Quality Index; Endoscopic thoracic sympathectomy; Hyperhidrosis; Hyperhidrosis Disease Severity Scale; Hyperhidrosis Impact Questionnaire; Impact; Quality of life

Mesh:

Year:  2014        PMID: 25152339     DOI: 10.1016/j.det.2014.06.004

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  14 in total

1.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

2.  Comparison of EQ-5D-3L and metabolic components between patients with hyperhidrosis and the general population: a propensity score matching analysis.

Authors:  Yea-Chan Lee; Young Kyung You; Jun Hyuk Lee; Duk Hwan Moon; Sungsoo Lee; Soyoung Jeon; Hye Sun Lee; Ji-Won Lee
Journal:  Qual Life Res       Date:  2021-05-11       Impact factor: 4.147

3.  Microneedling Delivery of Botulinum Toxin Versus Intradermal Injection in the Treatment of Facial Hyperhidrosis.

Authors:  Howyda Ebrahim; Amany Nassar; Mariam Mohammed Mousa; Elsayed Khater
Journal:  J Clin Aesthet Dermatol       Date:  2022-09

4.  Differences in subjective and objective evaluation of hyperhidrosis. Study among medical students.

Authors:  Łukasz Dobosz; Tomasz Stefaniak; Joanna Halman; Anna Piekarska
Journal:  Postepy Dermatol Alergol       Date:  2019-04-08       Impact factor: 1.837

Review 5.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

6.  Hyperhidrosis: an update on prevalence and severity in the United States.

Authors:  James Doolittle; Patricia Walker; Thomas Mills; Jane Thurston
Journal:  Arch Dermatol Res       Date:  2016-10-15       Impact factor: 3.017

7.  A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.

Authors:  Dee Anna Glaser; David M Pariser; Adelaide A Hebert; Ian Landells; Chris Somogyi; Emily Weng; Mitchell F Brin; Frederick Beddingfield
Journal:  Pediatr Dermatol       Date:  2015-06-08       Impact factor: 1.588

Review 8.  Oxybutynin as an alternative treatment for hyperhidrosis.

Authors:  Sergio Delort; Evaldo Marchi; Marcos Antônio Corrêa
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

9.  The quality of life and satisfaction rate of patients with upper limb hyperhidrosis before and after bilateral endoscopic thoracic sympathectomy.

Authors:  Waseem M Hajjar; Sami A Al-Nassar; Heba M Al-Sharif; Dana M Al-Olayet; Wejdan S Al-Otiebi; Alanoud A Al-Huqayl; Adnan W Hajjar
Journal:  Saudi J Anaesth       Date:  2019 Jan-Mar

10.  Development and validation of the Axillary Sweating Daily Diary: a patient-reported outcome measure to assess axillary sweating severity.

Authors:  L M Nelson; D DiBenedetti; D M Pariser; D A Glaser; A A Hebert; H Hofland; J Drew; D Ingolia; K K Gillard; S Fehnel
Journal:  J Patient Rep Outcomes       Date:  2019-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.